You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ST-1898, renal cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

Recruiting
  • Advanced Renal Cell Carcinoma
  • ST-1898 tablets
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Nov 6, 2023

Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)

Not yet recruiting
  • Urothelial Carcinoma of the Renal Pelvis and Ureter
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • (no location specified)
Nov 7, 2023

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Implementation of Shared Decision Making Strategy for Renal Cell

    Recruiting
    • Renal Cell Carcinoma
    • Renal Cell Carcinoma Metastatic
    • Decision aid
    • Nieuwegein, Utrecht, Netherlands
      St. Antonius Ziekenhuis
    Nov 28, 2022

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

    Available
    • Clear Cell Renal Cell Carcinoma
    • 89Zr-DFO-girentuximab
    • Los Angeles, California
      UCLA
    Oct 12, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 28, 2023

    Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

    Recruiting
    • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
    • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Sep 12, 2023

    Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • +2 more
    • (no location specified)
    May 14, 2023

    Among Advanced Renal Cell Carcinoma Receiving Systemic

    Not yet recruiting
    • Carcinoma, Renal Cell
      • (no location specified)
      Sep 6, 2022

      Renal Cell Carcinoma Trial (HS-10516)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 24, 2023

      Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Pembrolizumab injection
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 20, 2023

      Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

      Not yet recruiting
      • Renal Cell Carcinoma
      • +2 more
      • Implantable Microdevice (IMD)
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 17, 2023

      Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Sodium Pentaborate
      • Tabriz, East Azarbayejan, Iran, Islamic Republic of
        Imam Reza hospital and Clinic of Salamat
      Mar 23, 2023

      Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

      Not yet recruiting
      • Papillary Renal Cell Carcinoma
      • (no location specified)
      Nov 24, 2023

      Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Pucotenlimab Combined With Lenvatinib
      • Guangzhou, Other (Non U.s.), China
        Sun Yat-sen University Cancer Center
      Nov 10, 2023

      Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

      Not yet recruiting
      • Advanced Clear Cell Renal Carcinoma (Ccrcc)
      • Papillary Renal Cell Carcinoma (Prcc)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

      Completed
      • Carcinoma, Renal Cell
      • We do not have any interventions. This study is based on obseravation.
      • (no location specified)
      Oct 27, 2023

      Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • +3 more
      • Chengdu, Sichuan, China
        West China Hospital
      Apr 10, 2023

      Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

      Recruiting
      • Carcinoma, Renal Cell
      • Kidney Neoplasms
        • Yiwu, Zhejiang, China
          The Fourth Affiliated Hospital Zhejiang University School of Med
        Mar 27, 2023